Table 3 Cox regression multivariable model for overall survival. Patients over 70 years at diagnosis, patients who were ALCL-ALK +, patients who received no treatment or patients who lived less than 6 months from diagnosis were excluded, leaving a population of 199 patients.

From: A Finnish nationwide population-based study on the survival of patients with peripheral T-cell lymphoma

 

HR (95% CI)

p–value

Age

1.03 (1.01–1.05)

0.007

Advanced stage disease

1.50 (0.89–2.52)

0.127

Extranodal disease

1.63 (1.02–2.60)

0.04

Etoposide in induction treatment

1.11 (0.68–1.80)

0.676

Other chemo regimen

1.66 (0.93–2.96)

0.085

HDCT/ASCT completed

0.53 (0.34–0.83)

0.005

  1. HDCT/ASCT, high-dose chemotherapy and autologous stem cell transplantation; CI, confidence interval; HR, hazard ratio.
Back to article page